These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16942844)

  • 1. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM; Awad GA; Mortada ND; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):89-96. PubMed ID: 16942844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Mahajan HS; Gattani S
    Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of absorption enhancers on nasal absorption of acyclovir.
    Chavanpatil MD; Vavia PR
    Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal drug delivery of sumatriptan succinate.
    Chavanpatil MD; Vavia PR
    Pharmazie; 2005 May; 60(5):347-9. PubMed ID: 15918583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
    Mei D; Mao S; Sun W; Wang Y; Kissel T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
    Na L; Mao S; Wang J; Sun W
    Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
    du Plessis LH; Kotzé AF; Junginger HE
    Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats.
    Lu Y; Chen X; Du S; Wu Q; Yao Z; Zhai Y
    Arch Pharm Res; 2010 May; 33(5):691-6. PubMed ID: 20512466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
    Bortolotti F; Balducci AG; Sonvico F; Russo P; Colombo G
    Eur J Pharm Sci; 2009 Apr; 37(1):36-42. PubMed ID: 19162181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
    Zhang Y; Jiang XG; Yao J
    Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
    Khan SA; Patil KS; Yeole PG
    Pharmazie; 2008 May; 63(5):348-51. PubMed ID: 18557417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.